Bavarian Nordic A/S

DB:BV3 Stock Report

Market Cap: €2.1b

Bavarian Nordic Past Earnings Performance

Past criteria checks 5/6

Bavarian Nordic has been growing earnings at an average annual rate of 37.7%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 41.2% per year. Bavarian Nordic's return on equity is 10.5%, and it has net margins of 18.4%.

Key information

37.7%

Earnings growth rate

32.1%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate41.2%
Return on equity10.5%
Net Margin18.4%
Next Earnings Update05 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Bavarian Nordic makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:BV3 Revenue, expenses and earnings (DKK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 246,0701,1198741,663
30 Jun 246,0837077961,821
31 Mar 246,6429848052,115
31 Dec 237,0621,4757512,228
30 Sep 235,9067237571,757
30 Jun 235,5331,0767451,695
31 Mar 234,0833016301,376
31 Dec 223,151-3475891,183
30 Sep 222,404-599509755
30 Jun 221,849-693484470
31 Mar 221,683-606476382
31 Dec 211,898-465485399
30 Sep 211,583-737502409
30 Jun 211,693-629542437
31 Mar 212,022-368561397
31 Dec 201,852278564341
30 Sep 201,914606488325
30 Jun 201,499481398314
31 Mar 20901267303350
31 Dec 19662-347227387
30 Sep 19554-402217398
30 Jun 19631-271211379
31 Mar 19616-279215373
31 Dec 18501-362214386
30 Sep 18360-445218422
30 Jun 18873-151209511
31 Mar 181,1845206535
31 Dec 171,370181208518
30 Sep 171,745453205512
30 Jun 171,463225214482
31 Mar 171,182153211459
31 Dec 161,00731213463
30 Sep 16909-54215402
30 Jun 16536-202204349
31 Mar 16808-115205373
31 Dec 151,02159217375
30 Sep 151,244155229462
30 Jun 151,390186244507
31 Mar 151,16670242496
31 Dec 141,21726226479
30 Sep 141,013-99204425
30 Jun 141,107-61198406
31 Mar 141,293-12198512
31 Dec 131,213-47198497

Quality Earnings: BV3 has high quality earnings.

Growing Profit Margin: BV3's current net profit margins (18.4%) are higher than last year (12.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: BV3 has become profitable over the past 5 years, growing earnings by 37.7% per year.

Accelerating Growth: BV3's earnings growth over the past year (54.6%) exceeds its 5-year average (37.7% per year).

Earnings vs Industry: BV3 earnings growth over the past year (54.6%) exceeded the Biotechs industry -18.2%.

Return on Equity

High ROE: BV3's Return on Equity (10.5%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 10:41
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bavarian Nordic A/S is covered by 15 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peter AnkersenABG Sundal Collier
Jacob LademannCarnegie Investment Bank AB
Peter VerdultCitigroup Inc